Patel T

References (6)

Title : E2027 (irsenontrine), a phosphodiesterase 9 inhibitor, enhances cholinergic function when combined with donepezil hydrochloride - Ando_2025_Eur.J.Pharmacol_1006_178126
Author(s) : Ando M , Yamazaki K , Takahashi E , Kotani S , Patel T , Bradford A , Gartlon J , Norimine Y , Horie K
Ref : European Journal of Pharmacology , 1006 :178126 , 2025
Abstract :
PubMedSearch : Ando_2025_Eur.J.Pharmacol_1006_178126
PubMedID: 40914266

Title : E2027 (irsenontrine), a phosphodiesterase 9 inhibitor, enhances cholinergic function when combined with donepezil hydrochloride - Ando_2025_Eur.J.Pharmacol_1006_178126
Author(s) : Ando M , Yamazaki K , Takahashi E , Kotani S , Patel T , Bradford A , Gartlon J , Norimine Y , Horie K
Ref : European Journal of Pharmacology , 1006 :178126 , 2025
Abstract :
PubMedSearch : Ando_2025_Eur.J.Pharmacol_1006_178126
PubMedID: 40914266

Title : E2027 (irsenontrine), a phosphodiesterase 9 inhibitor, enhances cholinergic function when combined with donepezil hydrochloride - Ando_2025_Eur.J.Pharmacol_1006_178126
Author(s) : Ando M , Yamazaki K , Takahashi E , Kotani S , Patel T , Bradford A , Gartlon J , Norimine Y , Horie K
Ref : European Journal of Pharmacology , 1006 :178126 , 2025
Abstract :
PubMedSearch : Ando_2025_Eur.J.Pharmacol_1006_178126
PubMedID: 40914266

Title : Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases - Saxena_1998_Mol.Pharmacol_53_112
Author(s) : Saxena A , Ashani Y , Raveh L , Stevenson D , Patel T , Doctor BP
Ref : Molecular Pharmacology , 53 :112 , 1998
Abstract :
PubMedSearch : Saxena_1998_Mol.Pharmacol_53_112
PubMedID: 9443938

Title : Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases - Saxena_1998_Mol.Pharmacol_53_112
Author(s) : Saxena A , Ashani Y , Raveh L , Stevenson D , Patel T , Doctor BP
Ref : Molecular Pharmacology , 53 :112 , 1998
Abstract :
PubMedSearch : Saxena_1998_Mol.Pharmacol_53_112
PubMedID: 9443938

Title : Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases - Saxena_1998_Mol.Pharmacol_53_112
Author(s) : Saxena A , Ashani Y , Raveh L , Stevenson D , Patel T , Doctor BP
Ref : Molecular Pharmacology , 53 :112 , 1998
Abstract :
PubMedSearch : Saxena_1998_Mol.Pharmacol_53_112
PubMedID: 9443938